| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 5778 | 2008 |
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ... Проблемы медицинской микологии 5 (1), 10-16, 2003 | 2932 | 2003 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 2362 | 2020 |
| Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients ST Sonis, LS Elting, D Keefe, DE Peterson, M Schubert, M Hauer‐Jensen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 1788 | 2004 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1390 | 2012 |
| 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... European journal of cancer 47 (1), 8-32, 2011 | 1284 | 2011 |
| EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility … JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ... Clinical Microbiology and Infection 14 (4), 398-405, 2008 | 842* | 2008 |
| European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clin Infect Dis 46 (12), 1813-1821, 2008 | 765 | 2008 |
| Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis MASH Mennink-Kersten, JP Donnelly, PE Verweij The Lancet infectious diseases 4 (6), 349-357, 2004 | 701 | 2004 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 493 | 2012 |
| Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis C Mengoli, M Cruciani, RA Barnes, J Loeffler, JP Donnelly The Lancet infectious diseases 9 (2), 89-96, 2009 | 446 | 2009 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by … WW Hope, E Castagnola, AH Groll, E Roilides, M Akova, MC Arendrup, ... Clinical Microbiology and Infection 18, 38-52, 2012 | 412 | 2012 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell … AJ Ullmann, M Akova, R Herbrecht, C Viscoli, MC Arendrup, ... Clinical Microbiology and Infection 18, 53-67, 2012 | 396 | 2012 |
| Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and … S Ascioglu Clin Infect Dis. 34, 7-14, 2002 | 376 | 2002 |
| Aspergillus PCR: one step closer to standardization PL White, S Bretagne, L Klingspor, WJG Melchers, E McCulloch, B Schulz, ... Journal of clinical microbiology 48 (4), 1231-1240, 2010 | 342 | 2010 |
| Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview NMA Blijlevens, JP Donnelly, BE De Pauw Bone marrow transplantation 25 (12), 1269-1278, 2000 | 341 | 2000 |
| International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus PE Verweij, M Ananda-Rajah, D Andes, MC Arendrup, RJ Brüggemann, ... Drug Resistance Updates 21, 30-40, 2015 | 340 | 2015 |
| European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia JA Maertens, C Girmenia, RJ Brüggemann, RF Duarte, CC Kibbler, ... Journal of Antimicrobial Chemotherapy 73 (12), 3221-3230, 2018 | 332 | 2018 |
| Comparison of NCCLS and 3-(4, 5-dimethyl-2-thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development … J Meletiadis, JFGM Meis, JW Mouton, JP Donnelly, PE Verweij Journal of Clinical Microbiology 38 (8), 2949-2954, 2000 | 301 | 2000 |
| Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan CM Swanink, JF Meis, AJ Rijs, JP Donnelly, PE Verweij Journal of clinical microbiology 35 (1), 257-260, 1997 | 300 | 1997 |
Jacques F. Meis, MDUniversity of ColognePatvirtintas el. paštas uk-koeln.de